tiprankstipranks
Bionano Genomics initiated with an Outperform, $4 target at Scotiabank
The Fly

Bionano Genomics initiated with an Outperform, $4 target at Scotiabank

As previously reported, Scotiabank analyst Sung Ji Nam initiated coverage of Bionano Genomics with an Outperform rating and $4 price target. Bionano provides optical genome mapping technology tools and services to enable large-scale structural variation analysis of the genome, noted Ji Nam, who sees the company being "well positioned" to disrupt the cytogenetic testing market. He is projecting Bionano to deliver about 44% compound annual revenue growth over the next decade.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on BNGO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles